INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 109 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -84.0% | 13,691 | -69.2% | 0.00% | -100.0% |
| Q4 2021 | $100,000 | -63.1% | 44,434 | -50.9% | 0.00% | -66.7% |
| Q2 2021 | $271,000 | -63.2% | 90,500 | -60.4% | 0.00% | -66.7% |
| Q1 2021 | $737,000 | +2848.0% | 228,250 | +1615.5% | 0.01% | +800.0% |
| Q1 2019 | $25,000 | -82.3% | 13,305 | -50.3% | 0.00% | -87.5% |
| Q1 2016 | $141,000 | -28.8% | 26,772 | +6.4% | 0.01% | -33.3% |
| Q4 2015 | $198,000 | -25.6% | 25,173 | -20.1% | 0.01% | -7.7% |
| Q3 2015 | $266,000 | +58.3% | 31,501 | +105.5% | 0.01% | +62.5% |
| Q2 2015 | $168,000 | -85.2% | 15,330 | -81.2% | 0.01% | -85.7% |
| Q1 2015 | $1,137,000 | +28.3% | 81,350 | +55.0% | 0.06% | +16.7% |
| Q4 2014 | $886,000 | +2171.8% | 52,476 | +1709.5% | 0.05% | +2300.0% |
| Q3 2014 | $39,000 | – | 2,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $41,279,000 | 3.63% |
| NORTHPOINTE CAPITAL LLC | 528,739 | $1,433,000 | 0.21% |
| Opaleye Management Inc. | 275,000 | $745,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 364,401 | $988,000 | 0.12% |
| EcoR1 Capital, LLC | 462,068 | $1,252,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 990,748 | $2,685,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 284,354 | $771,000 | 0.04% |
| Fosun International Ltd | 358,859 | $879,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 97,630 | $200,000 | 0.04% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $81,000 | 0.04% |